Prescription drug prices in the United States - Wikipedia
Prescription drug prices in the United States have been among the highest in the world. The high cost of prescription drugs became a major topic of discussion in the new millennium, leading up to the U.S. health care reform debate of 2009, and received renewed attention in 2015. High prescription drug prices have been attributed to government-granted monopolies to manufacturers and organizations lacking ability to negotiate prices.[1]
Some of the highest prices include orphan drugs Lumizyme at $630,159 per patient in 2015, and Zolgensma at $2.1 million for a single-dose treatment in 2019. Several new treatments to cure Hepatitis C put a notable strain on insurance company and government health care budgets (including for prisons) due to the large patient population, resulting in rationing of the treatments. These include Harvoni at $91,589.40 per 12-week treatment in 2016, and simeprevir/sofosbuvir at $171,000 per treatment course in 2015.
Some of the highest prices include orphan drugs Lumizyme at $630,159 per patient in 2015, and Zolgensma at $2.1 million for a single-dose treatment in 2019. Several new treatments to cure Hepatitis C put a notable strain on insurance company and government health care budgets (including for prisons) due to the large patient population, resulting in rationing of the treatments. These include Harvoni at $91,589.40 per 12-week treatment in 2016, and simeprevir/sofosbuvir at $171,000 per treatment course in 2015.
Comment